Back to Results
First PageMeta Content
Dipeptidyl peptidase-4 inhibitor / Immunology / Infliximab / Rosiglitazone / Diabetes mellitus type 1 / Lixisenatide / GlaxoSmithKline / Medicine / Schering-Plough / Pharmacology


THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper than
Add to Reading List

Document Date: 2013-05-21 21:41:53


Open Document

File Size: 1,05 MB

Share Result on Facebook
UPDATE